Scinai Immunotherapeutics (SCNI) Short Interest Ratio & Short Volume

Short interest is the volume of Scinai Immunotherapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 8,800 shares of SCNI short. Learn More on Scinai Immunotherapeutics' current short interest.

Scinai Immunotherapeutics saw a drop in short interest in April. As of April 30th, there was short interest totaling 8,800 shares, a drop of 60.9% from the previous total of 22,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Scinai Immunotherapeutics: Acorda Therapeutics, Inc. (0.66%), Windtree Therapeutics, Inc. (2.99%), Finch Therapeutics Group, Inc. (4.88%), SciSparc Ltd. (4.18%), Sunshine Biopharma, Inc. (29.84%), Akanda Corp. (3.46%), Sintx Technologies, Inc. (7.78%), Evelo Biosciences, Inc. (2.11%), Bone Biologics Co. (3.87%), Tivic Health Systems, Inc. (3.74%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

Short selling SCNI is an investing strategy that aims to generate trading profit from Scinai Immunotherapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Scinai Immunotherapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SCNI, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SCNI, twice per month. The most recent reporting period available is April, 30 2024.